@article {Adwibowo2020.07.02.20145219, author = {Andrio Adwibowo}, title = {Computational fluid dynamic (CFD), air flow-droplet dispersion, and indoor CO2 analysis for healthy public space configuration to comply with COVID 19 protocol}, elocation-id = {2020.07.02.20145219}, year = {2020}, doi = {10.1101/2020.07.02.20145219}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {The droplet has a limited travel distance. Nonetheless, especially in the indoor public space the air flow can propagate the droplet to travel long distance. Based on this situation, this paper aims to study the relationships of seat configuration-social distance-air flow-droplet dispersions. The analysis was based on the computational fluid dynamic (CFD) using lattice-Boltzmann model (LBM). The result confirms that by modifying public space configuration in this case by providing more space and increasing seating distance can reduce the vulnerability towards droplet dispersions. Whereas, providing shield including adding protection is far more effective in avoiding dispersions. The public space reconfiguration including increasing seat distance and reducing seating capacity also has an effect in reducing the indoor CO2. Capacity reduction from full capacity to 30\% can decrease the CO2 from 5722 to 2144 ppm.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNAAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NAAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data are available in manuscript}, URL = {https://www.medrxiv.org/content/early/2020/07/06/2020.07.02.20145219}, eprint = {https://www.medrxiv.org/content/early/2020/07/06/2020.07.02.20145219.full.pdf}, journal = {medRxiv} }